Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of Inflammation
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2025.05.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Ladislav Król und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology, Oncology and Immunology, Skåne University Hospital, Lund, Sweden; Lund University Cancer Center, Lund University,…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft Rejection, Inflammation, T-Lymphocytes. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Märta Winklers foundation, ARMEC Lindeberg's Foundation, Childhood Cancer Foundation.
Abstract (Originalsprache)
BACKGROUND: Graft rejection (GR) is common complication after haploidentical hematopoietic cell transplantation (haplo-HCT). There are only a few studies describing the clinical presentation and potential risk factors of GR, and the optimal rescue strategy is not established. OBJECTIVES: To evaluate the cumulative incidence and potential risk factors for GR following haplo-HCT, and to compare survival, clinical symptoms, selected inflammatory parameters, and lactate dehydrogenase levels in patients with and without GR. METHODS: A retrospective single-center study including 79 patients (59 children and 20 adults) who underwent ex vivo T-cell-depleted haplo-HCT at Skåne University Hospital from 2001 to 2020. RESULTS: The cumulative incidence of GR was 14.8% (95% CI: 7.1-22.6). The median time to GR was 21 days (13-31). Five-year overall survival for patients without GR was 45.3% (95% CI: 32.8-57.7), and 41.7% (95% CI: 13.8-69.9) for those with GR (P = n.s.). None of the analyzed patient- and transplant-related factors were significantly associated with GR. Macular rash was the only GR-associated symptom. Patients with GR had higher median ferritin (18,096 µg/L; 1412-95,980) and lactate dehydrogenase (10.5 µkat/L, 0.7-35.0), and lower fibrinogen (2.65 g/L; 0.9-3.9) levels then patients who engrafted. CONCLUSIONS: In our cohort, GR was not associated with inferior survival and prompt retransplantation seems to be an effective rescue strategy. GR is characterized by increased levels of inflammation markers, while clinical symptoms are nonspecific. Further analysis in a larger cohort is necessary to assess whether regular monitoring of inflammatory parameters could guide preemptive treatment strategies for GR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology, Oncology and Immunology, Skåne University Hospital, Lund, Sweden; Lund University Cancer Center, Lund University, Lund, Sweden. Electronic address: ladislav.krol@med.lu.se.
- Department of Hematology, Skåne University Hospital, Lund, Sweden.
- Department of Pediatric Hematology, Oncology and Immunology, Skåne University Hospital, Lund, Sweden; Wallenberg Centre for Molecular Medicine and Division of Molecular Hematology, Lund University, Lund, Sweden.
- Department of Pediatric Hematology, Oncology and Immunology, Skåne University Hospital, Lund, Sweden; Center of Allogeneic Stem Cell Transplantation and Cellular Therapy, Karolinska University Hospital, Stockholm, Swede…
- Department of Pediatric Hematology, Oncology and Immunology, Skåne University Hospital, Lund, Sweden; Lund University Cancer Center, Lund University, Lund, Sweden.
- Clinical Immunology and Transfusion Medicine, Skåne University Hospital, Lund, Sweden.
Förderung
- Märta Winklers foundation
- ARMEC Lindeberg's Foundation
- Childhood Cancer Foundation
Zitieren
APA
Król, L., Wichert, S., Tomaszewska-Toporska, B., Lenhoff, S., Pronk, C. J., Toporski, J., Øra, I., Dykes, J., & Turkiewicz, D. (2025). Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of Inflammation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.05.025
Vancouver
Król L, Wichert S, Tomaszewska-Toporska B, Lenhoff S, Pronk CJ, Toporski J, et al. Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of Inflammation. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.05.025
BibTeX
@article{Krl2025,
author = {Król, Ladislav and Wichert, Stina and Tomaszewska-Toporska, Beata and Lenhoff, Stig and Pronk, Cornelis Jan and Toporski, Jacek and Øra, Ingrid and Dykes, Josefina and Turkiewicz, Dominik},
title = {Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of Inflammation},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2025.05.025}
}
EUVIMED